IGFBP2 attenuates high glucose-induced endothelial dysfunction through PI3K/Akt/eNOS pathway activation
Bioscience Reports · 18.11.2026 · 46 (11)
DOI: 10.1042/bsr20260182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience Reports, online erschienen am 29.10.2026. Verfasst von Xiaoyu Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Nitric Oxide Synthase Type III, Proto-Oncogene Proteins c-akt, Insulin-Like Growth Factor Binding Protein 2, Glucose. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Department of Finance of Jilin Province ().
Abstract (Originalsprache)
Endothelial dysfunction induced by hyperglycemia is a key event in diabetic vascular complications and is closely associated with impaired PI3K/Akt/endothelial nitric oxide synthase (eNOS) signaling. Insulin-like growth factor-binding protein 2 (IGFBP2) has been implicated in metabolic regulation and cell survival, but its role in high glucose (HG)-induced endothelial injury remains unclear. In the present study, human umbilical vein endothelial cells (HUVECs) were exposed to HG (33 mM) for 24 h and then treated with recombinant human IGFBP2 (rhIGFBP2, 200 ng/ml) for 60 min. HG reduced Akt/eNOS phosphorylation and nitric oxide (NO) production, increased the expression of ICAM-1, VCAM-1, and SELE, promoted interleukin-6, interleukin-8, monocyte chemoattractant protein-1 secretion, and enhanced apoptosis. rhIGFBP2 attenuated these HG-induced changes by restoring PI3K/Akt/eNOS signaling and NO production, reducing inflammatory activation, and decreasing apoptotic cell percentage. The effect of rhIGFBP2 on Akt/eNOS phosphorylation and NO production was broadly comparable to that of insulin under HG conditions. HG also increased p38 MAPK phosphorylation, whereas rhIGFBP2 showed only a nonsignificant decreasing trend. Importantly, PI3K inhibition with LY294002 abolished rhIGFBP2-induced Akt/eNOS activation, supporting the involvement of the PI3K/Akt/eNOS pathway. These findings suggest that IGFBP2 protects against HG-induced endothelial dysfunction mainly by activating PI3K/Akt/eNOS signaling and may represent a potential mediator of endothelial protection under diabetic conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, China.
- Department of Hematology, The First Hospital of Jilin University, Changchun, China.
ORCID-Profile: Xiaoyu Song
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Department of Finance of Jilin Province ()
Zitieren
APA
Song, X., Zhong, W., Chen, C., Zheng, H., & Li, Z. (2026). IGFBP2 attenuates high glucose-induced endothelial dysfunction through PI3K/Akt/eNOS pathway activation. Bioscience Reports, 46(11). https://doi.org/10.1042/bsr20260182
Vancouver
Song X, Zhong W, Chen C, Zheng H, Li Z. IGFBP2 attenuates high glucose-induced endothelial dysfunction through PI3K/Akt/eNOS pathway activation. Bioscience Reports. 2026;46(11). doi:10.1042/bsr20260182
BibTeX
@article{Song2026,
author = {Song, Xiaoyu and Zhong, Wentao and Chen, Chengqian and Zheng, Hao and Li, Zhuo},
title = {IGFBP2 attenuates high glucose-induced endothelial dysfunction through PI3K/Akt/eNOS pathway activation},
journal = {Bioscience Reports},
year = {2026},
volume = {46},
number = {11},
doi = {10.1042/bsr20260182}
}
EUVIMED